We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRPZ icon
9151
Invesco S&P SmallCap 600 GARP ETF
GRPZ
$3.24M
$72 ﹤0.01%
+3
New +$73
CONN
9152
DELISTED
Conn's Inc.
CONN
$72 ﹤0.01%
65
-669
-91% -$2.15K
HELP
9153
Cybin Inc
HELP
$485M
$71 ﹤0.01%
7
-58
-89% -$759
DRMAW icon
9154
Dermata Therapeutics Warrant
DRMAW
$14.1K
$71 ﹤0.01%
5,042
+3,557
+240% +$40
HEPA
9155
DELISTED
Hepion Pharmaceuticals
HEPA
$71 ﹤0.01%
1
-3
-75% -$221
ELTX icon
9156
Elicio Therapeutics
ELTX
$73.5M
$70 ﹤0.01%
17
+1
+6% +$8
KEUA
9157
DELISTED
KraneShares European Carbon Allowance Strategy ETF
KEUA
$68 ﹤0.01%
3
-230
-99% -$5.44K
YYGH
9158
YY Group Holding Ltd
YYGH
$3.84M
0
KITT icon
9159
Nauticus Robotics
KITT
$5.97M
-10
Closed -$4.82K
XXII
9160
22nd Century Group
XXII
$1.38M
0
PNBK icon
9161
Patriot National Bancorp
PNBK
$134M
$65 ﹤0.01%
35
-8
-19% -$23
RPID icon
9162
Rapid Micro Biosystems
RPID
$106M
$65 ﹤0.01%
98
-148
-60% -$127
BYNOW
9163
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
$65 ﹤0.01%
+2,600
New +$139
IQDE
9164
DELISTED
FlexShares International Quality Dividend Defensive Index Fund
IQDE
$65 ﹤0.01%
3
-78
-96% -$1.71K
CARU icon
9165
MAX Auto Industry 3x Leveraged ETN
CARU
$3.62M
$64 ﹤0.01%
3
-52
-95% -$998
EFTRW
9166
DELISTED
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
$64 ﹤0.01%
63,645
+63,001
+9,783% +$2.17K
CMPOW
9167
DELISTED
CompoSecure Inc Warrant
CMPOW
$61 ﹤0.01%
+136
New +$61
UBR icon
9168
ProShares Ultra MSCI Brazil Capped
UBR
$3.98M
$61 ﹤0.01%
3
-2
-40% -$50
SPQ
9169
DELISTED
Simplify US Equity PLUS QIS ETF
SPQ
$60 ﹤0.01%
2
-1
-33% -$29
CALC icon
9170
CalciMedica
CALC
$15.8M
$59 ﹤0.01%
15
-1
-6% -$5
NDIV icon
9171
Amplify Energy & Natural Resources Covered Call ETF
NDIV
$27M
$58 ﹤0.01%
+2
New +$58
AEAE
9172
DELISTED
AltEnergy Acquisition Corp
AEAE
$56 ﹤0.01%
5
AGRIW
9173
DELISTED
AgriFORCE Growing Systems Ltd Warrant
AGRIW
$56 ﹤0.01%
+5,589
New +$44
RENEW
9174
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
$55 ﹤0.01%
+546
New +$60
UWMC.WS
9175
DELISTED
UWM Holdings Warrants
UWMC.WS
$55 ﹤0.01%
240
-3
-1% -$1

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.